Stem cells in melanoma development

Cancer Letters

Volumn 279, Issue 2, 2009, Pages 119-125

  Sabatino, Marianna ^a   Stroncek, David F ^a   Klein, Harvey ^a   Marincola, Francesco M ^a   Wang, Ena ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cancer stem cells; Melanoma stem cells

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B5; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD20 ANTIGEN; CD24 ANTIGEN; HERMES ANTIGEN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

BRAIN TUMOR; CANCER STEM CELL; CELL RENEWAL; CELL SUBPOPULATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; DNA REPAIR; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; GENOMIC INSTABILITY; GLIOBLASTOMA; HISTORY; HUMAN; MEDULLOBLASTOMA; MELANOMA; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SOLID TUMOR; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR REGRESSION;

EID: 67349278038     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.039     Document Type: Review

References (64)

1. Beddingfield III F.C. The melanoma epidemic: res ipsa loquitur. Oncologist 8 (2003) 459-465
2. Rietschel P., Wolchok J.D., Krown S., Gerst S., Jungbluth A.A., Busam K., Smith K., Orlow I., Panageas K., and Chapman P.B. Phase II study of extended-dose temozolomide in patients with melanoma. J. Clin. Oncol. 26 (2008) 2299-2304
3. Dudley M.E., Wunderlich J.R., Yang J.C., Sherry R.M., Topalian S.L., Restifo N.P., Royal R.E., Kammula U., White D.E., Mavroukakis S.A., Rogers L.J., Gracia G.J., Jones S.A., Mangiameli D.P., Pelletier M.M., Gea-Banacloche J., Robinson M.R., Berman D.M., Filie A.C., Abati A., and Rosenberg S.A. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma. J. Clin. Oncol. 23 (2005) 2346-2357
4. Reya T., Morrison S.J., Clarke M.F., and Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 414 (2001) 105-111
5. Odoux C., Fohrer H., Hoppo T., Guzik L., Stolz D.B., Lewis D.W., Gollin S.M., Gamblin T.C., Geller D.A., and Lagasse E. A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res. 68 (2008) 6932-6941
6. Lagasse E. Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer. Gene Ther. 15 (2008) 136-142
7. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
8. Seaberg R.M., and van der K.D. Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci. 26 (2003) 125-131
9. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
10. Michor F., Iwasa Y., Vogelstein B., Lengauer C., and Nowak M.A. Can chromosomal instability initiate tumorigenesis?. Semin. Cancer Biol. 15 (2005) 43-49
11. Rosenberg S.A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today 18 (1997) 175-182
12. Kvinlaug B.T., and Huntly B.J. Targeting cancer stem cells. Expert Opin. Ther. Targets 11 (2007) 915-927
13. Guo W., Lasky III J.L., and Wu H. Cancer stem cells. Pediatr. Res. 59 (2006) 59R-64R
14. Minden M.D., Buick R.N., and McCulloch E.A. Separation of blast cell and T-lymphocyte progenitors in the blood of patients with acute myeloblastic leukemia. Blood 54 (1979) 186-195
15. Adamson J.W., Fialkow P.J., Murphy S., Prchal J.F., and Steinmann L. Polycythemia vera: stem-cell and probable clonal origin of the disease. N. Engl. J. Med. 295 (1976) 913-916
16. Fialkow P.J., Najfeld V., Reddy A.L., Singer J., and Steinmann L. Chronic lymphocytic leukaemia: clonal origin in a committed B-lymphocyte progenitor. Lancet 2 (1978) 444-446
17. Lapidot T., Sirard C., Vormoor J., Murdoch B., Hoang T., Caceres-Cortes J., Minden M., Paterson B., Caligiuri M.A., and Dick J.E. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 (1994) 645-648
18. Bonnet D., and Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 (1997) 730-737
19. Wang E., Voiculescu S., Le Poole I.C., el Gamil M., Li X., Sabatino M., Robbins P.F., Nickoloff B.J., and Marincola F.M. Clonal persistence and evolution during a decade of recurrent melanoma. J. Invest. Dermatol. 126 (2006) 1372-1377
20. Sabatino M., Zhao Y., Voiculescu S., Monaco A., Robbins P.F., Nickoloff B.J., Karai L., Selleri S., Maio M., Selleri S., Marincola F.M., and Wang E. Conservation of a core of genetic alterations over a decade of recurrent melanoma supports the melanoma stem cell hypothesis. Cancer Res. 68 (2008) 222-231
21. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
22. Pathak S. Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res. 22 (2002) 1353-1356
23. Al-Hajj M., Wicha M.S., ito-Hernandez A., Morrison S.J., and Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003) 3983-3988
24. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., and Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. USA 100 (2003) 15178-15183
25. Mizrak D., Brittan M., and Alison M.R. CD133: molecule of the moment. J. Pathol. 214 (2008) 3-9
26. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., and Dirks P.B. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
27. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De V.S., Fiocco R., Foroni C., Dimeco F., and Vescovi A. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64 (2004) 7011-7021
28. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
29. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., and De M.R. Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007) 111-115
30. O'Brien C.A., Pollett A., Gallinger S., and Dick J.E. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (2007) 106-110
31. Grichnik J.M., Ali W.N., Burch J.A., Byers J.D., Garcia C.A., Clark R.E., and Shea C.R. KIT expression reveals a population of precursor melanocytes in human skin. J. Invest. Dermatol. 106 (1996) 967-971
32. Nishimura E.K., Jordan S.A., Oshima H., Yoshida H., Osawa M., Moriyama M., Jackson I.J., Barrandon Y., Miyachi Y., and Nishikawa S. Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416 (2002) 854-860
33. Yu H.S. Melanocyte destruction and repigmentation in vitiligo: a model for nerve cell damage and regrowth. J. Biomed. Sci. 9 (2002) 564-573
34. Nishimura E.K., Granter S.R., and Fisher D.E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307 (2005) 720-724
35. Grichnik J.M. Genomic instability and tumor stem cells. J. Invest. Dermatol. 126 (2006) 1214-1216
36. Grichnik J.M., Burch J.A., Schulteis R.D., Shan S., Liu J., Darrow T.L., Vervaert C.E., and Seigler H.F. Melanoma, a tumor based on a mutant stem cell?. J. Invest. Dermatol. 126 (2006) 142-153
37. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., Van Belle P.A., Xu X., Elder D.E., and Herlyn M. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res. 65 (2005) 9328-9337
38. Monzani E., Facchetti F., Galmozzi E., Corsini E., Benetti A., Cavazzin C., Gritti A., Piccinini A., Porro D., Santinami M., Invernici G., Parati E., Alessandri G., and La Porta C.A. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur. J. Cancer 43 (2007) 935-946
39. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
40. Kondo T., Setoguchi T., and Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 101 (2004) 781-786
41. Frank N.Y., Pendse S.S., Lapchak P.H., Margaryan A., Shlain D., Doeing C., Sayegh M.H., and Frank M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 278 (2003) 47156-47165
42. Frank N.Y., Margaryan A., Huang Y., Schatton T., Waaga-Gasser A.M., Gasser M., Sayegh M.H., Sadee W., and Frank M.H. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 65 (2005) 4320-4333
43. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., Zhan Q., Jordan S., Duncan L.M., Weishaupt C., Fuhlbrigge R.C., Kupper T.S., Sayegh M.H., and Frank M.H. Identification of cells initiating human melanomas. Nature 451 (2008) 345-349
44. Keshet G.I., Goldstein I., Itzhaki O., Cesarkas K., Shenhav L., Yakirevitch A., Treves A.J., Schachter J., Amariglio N., and Rechavi G. MDR1 expression identifies human melanoma stem cells. Biochem. Biophys. Res. Commun. 368 (2008) 930-936
45. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., and Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and A. Cancer Res. 65 (2005) 6207-6219
46. Blagosklonny M.V. Cancer stem cell and cancer stemloids: from biology to therapy. Cancer Biol. Ther. 6 (2007) 1684-1690
47. Klein W.M., Wu B.P., Zhao S., Wu H., Klein-Szanto A.J., and Tahan S.R. Increased expression of stem cell markers in malignant melanoma. Mod. Pathol. 20 (2007) 102-107
48. Kwong J., Lo K.W., Chow L.S., To K.F., Choy K.W., Chan F.L., Mok S.C., and Huang D.P. Epigenetic silencing of cellular retinol-binding proteins in nasopharyngeal carcinoma. Neoplasia 7 (2005) 67-74
49. Huang J., Wei W., Zhang J., Liu G., Bignell G.R., Stratton M.R., Futreal P.A., Wooster R., Jones K.W., and Shapero M.H. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum. Genomics 1 (2004) 287-299
50. Storchova Z., and Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5 (2004) 45-54
51. Bevilacqua R.A., Nunes D.N., Stroun M., and Anker P. The use of genetic instability as a clinical tool for cancer diagnosis. Semin. Cancer Biol. 8 (1998) 447-453
52. Curtin J.A., Fridlyand J., Kageshita T., Patel H.N., Busam K.J., Kutzner H., Cho K.H., Aiba S., Brocker E.B., LeBoit P.E., Pinkel D., and Bastian B.C. Distinct sets of genetic alterations in melanoma. N. Engl. J. Med. 353 (2005) 2135-2147
53. Bastian B.C., LeBoit P.E., Hamm H., Brocker E.B., and Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 58 (1998) 2170-2175
54. Balazs M., Adam Z., Treszl A., Begany A., Hunyadi J., and Adany R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 46 (2001) 222-232
55. Durante F. Nesso phisio-patologico tra la struttura dei nei materni e la genesi di alcuni tumori maligni. Arch. Memor. Observ. Chir. Pract. 11 (1874) 217-226
56. Wicha M.S., Liu S., and Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 66 (2006) 1883-1890
57. Costa F.F., Le B.K., and Brodin B. Concise review: cancer/testis antigens, stem cells, and cancer. Stem Cells 25 (2007) 707-711
58. Robbins P.F., el-Gamil M., Li Y.F., Kawakami Y., Loftus D., Appella E., and Rosenberg S.A. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med. 183 (1996) 1185-1192
59. Lennerz V., Fatho M., Gentilini C., Frye R.A., Lifke A., Ferel D., Wolfel C., Huber C., and Wolfel T. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl. Acad. Sci. USA 102 (2005) 16013-16018
60. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr. Opin. Oncol. 19 (2007) 61-64
61. Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., and Wahl G.M. Cancer stem cells - perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Res. 66 (2006) 9339-9344
62. Greijer A.E., van der G.P., Kemming D., Shvarts A., Semenza G.L., Meijer G.A., van de Wiel M.A., Belien J.A., van Diest P.J., and van der W.E. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J. Pathol. 206 (2005) 291-304
63. Kelly P.N., Dakic A., Adams J.M., Nutt S.L., and Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 317 (2007) 337
64. Husemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmuller G., and Klein C.A. Systemic spread is an early step in breast cancer. Cancer Cell 13 (2008) 58-68